These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25008344)

  • 121. Talarolutins A-D: Meroterpenoids from an endophytic fungal isolate of Talaromyces minioluteus.
    Kaur A; Raja HA; Swenson DC; Agarwal R; Deep G; Falkinham JO; Oberlies NH
    Phytochemistry; 2016 Jun; 126():4-10. PubMed ID: 27048854
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Quantitative prediction and clinical evaluation of an unexplored herb-drug interaction mechanism in healthy volunteers.
    Gufford BT; Barr JT; González-Pérez V; Layton ME; White JR; Oberlies NH; Paine MF
    CPT Pharmacometrics Syst Pharmacol; 2015 Dec; 4(12):701-10. PubMed ID: 26904384
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides.
    Gufford BT; Graf TN; Paguigan ND; Oberlies NH; Paine MF
    Drug Metab Dispos; 2015 Nov; 43(11):1734-43. PubMed ID: 26316643
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Interactions between CYP3A4 and Dietary Polyphenols.
    Basheer L; Kerem Z
    Oxid Med Cell Longev; 2015; 2015():854015. PubMed ID: 26180597
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance.
    Barr JT; Jones JP; Oberlies NH; Paine MF
    Drug Metab Dispos; 2015 Jan; 43(1):34-41. PubMed ID: 25326286
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Natural and synthetic inhibitors of UDP-glucuronosyltransferase.
    Grancharov K; Naydenova Z; Lozeva S; Golovinsky E
    Pharmacol Ther; 2001 Feb; 89(2):171-86. PubMed ID: 11316519
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidation.
    Gufford BT; Chen G; Lazarus P; Graf TN; Oberlies NH; Paine MF
    Drug Metab Dispos; 2014 Oct; 42(10):1675-83. PubMed ID: 25008344
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (
    Tian DD; Kellogg JJ; Okut N; Oberlies NH; Cech NB; Shen DD; McCune JS; Paine MF
    Drug Metab Dispos; 2018 May; 46(5):552-560. PubMed ID: 29467215
    [TBL] [Abstract][Full Text] [Related]  

  • 129. A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors.
    Brantley SJ; Graf TN; Oberlies NH; Paine MF
    Drug Metab Dispos; 2013 Sep; 41(9):1662-70. PubMed ID: 23801821
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction.
    Gufford BT; Chen G; Vergara AG; Lazarus P; Oberlies NH; Paine MF
    Drug Metab Dispos; 2015 Sep; 43(9):1353-9. PubMed ID: 26070840
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
    Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction.
    Brantley SJ; Gufford BT; Dua R; Fediuk DJ; Graf TN; Scarlett YV; Frederick KS; Fisher MB; Oberlies NH; Paine MF
    CPT Pharmacometrics Syst Pharmacol; 2014 Mar; 3(3):e107. PubMed ID: 24670388
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Herb-drug interactions: challenges and opportunities for improved predictions.
    Brantley SJ; Argikar AA; Lin YS; Nagar S; Paine MF
    Drug Metab Dispos; 2014 Mar; 42(3):301-17. PubMed ID: 24335390
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Prodrugs of quercetin and resveratrol: a strategy under development.
    Biasutto L; Zoratti M
    Curr Drug Metab; 2014 Jan; 15(1):77-95. PubMed ID: 24329110
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.
    Chengcheng G; Rui X; Tianheng M; Wei Y; Liqun P
    Afr Health Sci; 2013 Sep; 13(3):551-5. PubMed ID: 24250287
    [TBL] [Abstract][Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.